REFERENCES

• CalabreseJR.HirschfeldRM.FryeMA.ReedML.Impact of depressive symptoins compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample.J Clin Psychiatry.2004651499150415554762
   PubMed Web of Science ®Google Scholar
• JuddLL.AkiskalHS.SchettlerPJ.et al.Psychosocial disability in the course of bipolar I and II disorders: A prospective, comparative, longitudinal study.Arch Gen Psychiatry.2005621322133016330720
   PubMed Web of Science ®Google Scholar
• TondoL.IcacssonG.BaldessariniR.Suicidal behaviour in bipolar disorder: risk and prevention.CNS Drugs.20031749151112751919
   PubMed Web of Science ®Google Scholar
• TseSS.WalshAE.How does work work for people with bipolar affective disorder?Occup Ther int.2001821022511823884
   PubMedGoogle Scholar
• KupferDJ.The increasing medical burden in bipolar disorder.JAMA.20052932528253015914754
   PubMed Web of Science ®Google Scholar
• KleinmanNL.BrookRA.RajagopalanK.GardnerHH.BrizeeTJ.SmeedingJE.Lost time, absence costs, and reduced productivity output for employees with bipolar disorder.J Occup Environ Med.2005471117112416282872
   PubMed Web of Science ®Google Scholar
• VojtaC.KinosianB.ClickH.AltshulerL.BauerMS.Self-reported quality of life across mood states in bipolar disorder.Compr Psychiatry.20014219019511349236
   PubMed Web of Science ®Google Scholar
• AltshulerLL.PostRM.BlackDO.et al.Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: Results of a large, multisite study.J Clin Psychiatry.2006671551156017107246
   PubMed Web of Science ®Google Scholar
• JuddLL.AkiskalAH.SchettlerPJ.et al.The long-term natural history of the weekly symptomatic status of bipolar I disorder.Arch Gen Psychiatry.20025953053712044195
   PubMed Web of Science ®Google Scholar
• JuddLL.AkiskalAH.SchettlerPJ.et al.A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.Arch Gen Psychiatry.20036026126912622659
   PubMed Web of Science ®Google Scholar
• SuppesT.KellyDl.PerlaJM.Challenges in the management of bipolar depression.J Clin Psychiatry.200566(S5)111616038597
   PubMed Web of Science ®Google Scholar
• KupkaRW.AltshulerLL.NolenWA.et al.Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.Bipolar Disord.2007953153517680925
   PubMed Web of Science ®Google Scholar
• PerlisRH.OstacherMJ.PatelJK.et al.Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).Am J Psychiatry.200616321722416449474
   PubMed Web of Science ®Google Scholar
• GijsmanHJ.GeddesJR.RendellJM.NolenWA.GoodwinGM.Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.Am J Psychiatry20041611537154715337640
   PubMed Web of Science ®Google Scholar
• SachsGS.NierenbergAA.CalabreseJR.et al.Effectiveness of adjunctive antidepressant treatment for bipolar depression. W.N Engl J Med.20073561711112217392295
   PubMed Web of Science ®Google Scholar
• ZornbergGL.Pope HGJr.Treatment of depression in bipolar disorder: new directions for research.J Clin Psychopharmacol.1993133974088120153
   PubMed Web of Science ®Google Scholar
• CavanaghJ.SmythR.GoodwinGM.Relapse into mania or depression following lithium discontinuation: a 7-year follow-up.Acta Psychiatr Scand.2004109919514725588
   PubMed Web of Science ®Google Scholar
• NemeroffCB.EvansDL.GyulaiL.et al.Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.Am J Psychiatry.200115890691211384898
   PubMed Web of Science ®Google Scholar
• BaldessariniRJ.TondoL.DavisP.PompiliM.GoodwinFK.HennenJ.Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.Bipolar Disord.2006862563917042835
   PubMed Web of Science ®Google Scholar
• GoodwinFK.FiremanB.SimonGE.HunkelerEM.LeeJ.RevickiD.Suicide risk in bipolar disorder during treatment with lithium and divalproex.JAMA.20032901467147313129986
   PubMed Web of Science ®Google Scholar
• CalabreseJR.BowdenCL.SachsGS.AscherJA.MonaghanE.RuddGD.A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.J Clin Psychiatry.199960798810084633
   PubMed Web of Science ®Google Scholar
• CalabreseJR.HuffmanRF.WhiteRL.et al.Lamotrigine in the acute treatment of bipolar depression: results of five, double-blind, placebo-controlled clinical trials.Bipolar Disord.20081032333318271912
   PubMed Web of Science ®Google Scholar
• CalabreseJR.SuppesT.BowdenCL.et al.A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder.J Clin Psychiatry.20006184185011105737
   PubMed Web of Science ®Google Scholar
• van der LoosMLM.ZwolleIK.VietaE.et al.Lamotrigine as add-on to lithium in bipolar depression. Poster presented at: Seventh International Conference on Bipolar Disorder, Pittsburgh, Pennsylvania. June 7-9. 2007
   Google Scholar
• BallengerJC.PostRM.Carbamazepine in manic-depressive illness: a new treatment.Am J Psychiatry.19801377827907386656
   PubMed Web of Science ®Google Scholar
• PostRM.UhdeTW.Roy-ByrnePP.JoffeRT.Antidepressant effects of carbamazepine.Am J Psychiatry.198614329343510572
   PubMed Web of Science ®Google Scholar
• WinsbergME.DeGoliaSG.StrongCM.KetterTA.Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression.J Affect Disord.20016720721211869770
   PubMed Web of Science ®Google Scholar
• SachsGS.AltshulerLL.KetterT.et al.Divalproex versus placebo for the treatment of bipolar depression. Poster presented at: American College of Neuropsychopharmacology 40th Meeting, Waikoloa, Hawaii. December 9-13. 2001
   Google Scholar
• DavisLL.BartolucciA.PettyF.Divalproex in the treatment of bipolar depression: a placebo-controlled study.J Affect Disord.20058525926615780695
   PubMed Web of Science ®Google Scholar
• GhaemlSN.GilmerWS.GoldbergJF.et al.Divalproex in the treatment of acute bipolar depression: a randomized, placebo-controlled pilot study.J Clin Psychiatry.2007681840184418162014
   PubMed Web of Science ®Google Scholar
• TohenM.VietaE.CalabreseJ.et al.Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.Arch Gen Psychiatry.2003601079108814609883
   PubMed Web of Science ®Google Scholar
• American Diabetes Association, Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes.Diabetes Care.20042759660114747245
   PubMed Web of Science ®Google Scholar
• CalabreseJR.Keck PEJr.MacfaddenW.et al.A randomized, doubleblind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.Am J Psychiatry.20051621351136015994719
   PubMed Web of Science ®Google Scholar
• ThaseME.MacfaddenW.WeislerRH.et al.Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).J Clin Psychopharmacol.20062660060917110817
   PubMed Web of Science ®Google Scholar
• GoldsteinJM.ChristophG.GrimmS.LiuJW.WidzowskiD.BrecherM.Unique mechanism of action for the antidepressant properties of the atypical antipyshcotic quetiapine. Poster presented at: 160th Annual Meeting of the American Psychiatric Association, San Diego, California. May 19-24. 2007
   Google Scholar
• BarbeeJG.ConradEJ.JamhourNJ.Aripiprazole augmentation in treatment-resistant depression.Ann Clin Psychiatry.20041618919415702566
   PubMedGoogle Scholar
• KetterTA.WangPW.ChandlerRA.CulverJL.AlarconAM.Adjunctive aripiprazole in treatment-resistant bipolar depression.Ann Clin Psychiatry.20061816917216923655
   PubMedGoogle Scholar
• KempDE.DagoPL.StrausJ.FleckJ.KaraffaM.GilmerWS.Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months.J Clin Psychopharmacol.20072730430517502781
   PubMed Web of Science ®Google Scholar
• ThaseME.JonasA.KhanA.et al.Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.J Clin Psychopharmacol.200828132018204335
   PubMed Web of Science ®Google Scholar
• ThaseME.Pharmacotherapy of bipolar depression: an update.Curr Psychiatry Rep.2006847848817094928
   PubMedGoogle Scholar
• CooksonJ.KeckPE.KetterTA.MacfaddenW.Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study,Int Clin Psychopharmacol.2007229310017293709
   PubMed Web of Science ®Google Scholar
• NierenbergAA.OstacherMJ.CalabreseJR.et al.Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.Am J Psychiatry.200616321021616449473
   PubMed Web of Science ®Google Scholar
• GhaemiSN.HsuDJ.SoldaniF.GoodwinFK.Antidepressants in bipolar disorder: the case for caution.Bipolar Disord.2003542143314636365
   PubMed Web of Science ®Google Scholar
• CalabreseJR.BowdenCL.SachsG.et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.J Clin Psychiatry.2003641013102414628976
   PubMed Web of Science ®Google Scholar
• BowdenCL.CalabreseJR.SachsG.et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.Arch Gen Psychiatry.20036039240012695317
   PubMed Web of Science ®Google Scholar
• TohenM.CalabreseJR.SachsG.et al.placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.Am J Psychiatry.200616324725616449478
   PubMed Web of Science ®Google Scholar
• Keck PEJr.CalabreseJR.McQuadeRD.et al.A randomized, doubleblind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.J Clin Psychiatry.20066762663716669728
   PubMed Web of Science ®Google Scholar
• BowdenCL.CalabreseJR.McElroySL.et al.A randomized, placebocontrolled 12 -month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.Arch Gen Psychiatry.20005748148910807488
   PubMed Web of Science ®Google Scholar
• GyulaiL.BowdenCL.McElroySL.et al.Maintenance efficacy of divalproex in the prevention of bipolar depression.Neuropsychopharmacology.2003281374138212784116
   PubMed Web of Science ®Google Scholar
• CalabreseJR.VietaE.El-MallakhR.et al.Mood state at study entry as predictor of the polarity of relapse in bipolar disorder.Biol Psychiatry.20045695796315601606
   PubMed Web of Science ®Google Scholar
• BrecherM.LiuS.PaulssonB.Quetiapine in the maintenance treatment of bipolar I disorder: combined data from two long-term, phase III studies. Poster presented at: 16th European Congress of Psychiatry, Nice, France. April 5-9, 2008
   Google Scholar
• CoryaSA.PerlisRH.Keck PEJr.et al.A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.J Clin Psychiatry.20066779880616841630
   PubMed Web of Science ®Google Scholar
• HirschfeldRMA.PanagidesJ.AlphsL.CohenM.LancasterS.MacekT.Asenapine in acute mania: A randomized, double-blind, placebo- and olanzapine-controlled trial (ARES 7501005). Poster presented at: 160th Annual Meeting of the American Psychiatric Association, San Diego, CA. May 1924 2007
   Google Scholar
• RapaportM.BarbatoLM.HeisterbergJ.YeungPP.ShapiraNA.Efficacy and safety of bifeprunox versus placebo in the treatment of patients with acute exacerbations of schizophrenia.Neuropsychopharmacology.200631S184
   Web of Science ®Google Scholar
• ShapiraNA.NewcomerJW.HeisterbergJ.YeungPP.BarbatoLM.The metabolic profile of bifeprunox in the treatment of patients with schizophrenia.Neuropsychopharmacology.200731S175S176
   Web of Science ®Google Scholar
• FryeM.GrunzeH.SuppesT.et al.A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.Am J Psychiatry.2007161242124917671288
   PubMedGoogle Scholar
• KonradiC.EatonM.MacDonaldML.WalshJ.BenesFM.HeckersS.Molecular evidence for mitochondrial dysfunction in bipolar disorder.Arch Gen Psychiatry.20046130030814993118
   PubMed Web of Science ®Google Scholar
• PostRM.DenicoffKD.LeverichGS.et al.Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.J Clin Psychiatry.20036468069012823083
   PubMed Web of Science ®Google Scholar
• BaldessariniRJ.LeahyL.ArconaS.et al.Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.Psychiatric Services.200758859117215417
   PubMed Web of Science ®Google Scholar
• AltshulerLL.SuppesT.BlackD.et al.Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.Am J Psychiatry.20031601252126212832239
   PubMed Web of Science ®Google Scholar
• MiklowitzDJ.OttowMW.FrankE.et al.Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.Arch Gen Psychiatry.20076441942617404119
   PubMed Web of Science ®Google Scholar